The company recently raised an additional $6.5 million to supplement the initial $11.6 million, which was announced in July 2014. HealthQuest Capital led the extension.
The funds will be used to support the company’s commercialization and marketing of its diagnostic arthroscopy product, Mi-eye.
More articles on devices:
27 spine devices receive FDA 510(k) clearance in January
MiMedx withdraws complaint against Organogenesis
NuVasive COO sells 15k shares — 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
